ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit.
Green
John A
JA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D016190:Carboplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017239:Paclitaxel / Q000008:administration & dosage; D017671:Platinum Compounds / Q000008:administration & dosage; D016896:Treatment Outcome
D017671:Platinum Compounds; D016190:Carboplatin; D017239:Paclitaxel